Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical
London, 13th April 2021 | Medical compliance and technical review capability strengthen imc group’s offering
Indigo Medical, a leading provider of material review, medical signatory approval services and medical communication for global pharmaceutical and biopharma companies, is joining imc group with the backing of pan-European investor Waterland Private Equity. The new partnership enhances imc group’s increasing geographic footprint and capabilities, as well as disrupts the global healthcare communications industry with a one-stop service for clients across seven core divisions: Medical & Scientific Content, Publications, Digital & Creative, Insights & Consulting, Patient Engagement, Meetings & Events, and Medical Compliance & Material Review.